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Abstract
Purpose Total knee arthroplasty (TKA) is the treatment of choice for end-stage osteoarthritis though its risk-benefit ratio in
elderly patients remains debated. This study aimed to evaluate the functional outcome, rates of complication and mortality, and
quality-adjusted life years (QALY) in patients who exceeded their estimated life expectancy.
Methods Ninety-seven TKA implanted in 86 patients who exceeded their estimated life expectancy at the time of TKA were
prospectively included in our institutional joint registry and retrospectively analyzed. At latest follow-up, the functional outcome
with the Knee Society Score (KSS), rates of complication and mortality, and QALY with utility value of EuroQol-5D score were
evaluated.
Results At a mean follow-up of three ± one years, the pre- to post-operative KSS improved significantly (p < 0.01). The rates of
surgical andmajor medical complications related to TKAwere 3% and 10%, respectively. The re-operation rate with readmission
was 3% while no TKA was revised. The 30-day and one year mortality was 1% and 3%, respectively. The pre- to one year post-
operative QALY improved significantly (p < 0.01). The cumulative QALY five years after TKA was four years. Assuming that
these patients did not undergo TKA, their cumulative QALY at five years would have been only two years.
Conclusion TKA is an effective procedure for the treatment of end-stage osteoarthritis in patients who exceeded their estimated
life expectancy. TKA provided significant improvement in function and quality of life without adversely affecting overall
morbidity and mortality. Therefore, TKA should not be contra-indicated in elderly patients based on their advanced age alone.
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Introduction
End-stage knee osteoarthritis (OA) is a major cause of disabil-
ity and functional decline with loss of independence in elderly
patients [1]. Total knee arthroplasty (TKA) is an effective
surgical treatment that provides relief of pain, functional res-
toration, and improvement in overall quality of life in patients
suffering from knee OA [2, 3]. However, as any major surgi-
cal procedure, TKA could be challenging when performed in
patients who exceeded their estimated life expectancy regard-
ing potential occurrence of post-operative medical- or
surgical-related complications that may affect the overall mor-
bidity and mortality [4, 5]. Previous studies reported that total
joint arthroplasties in elderly patients were associated with
higher risk of post-operative adverse events with longer in-
hospital stay duration and higher readmission rate [6–9]. In
addition, using a risk-estimation model, Klausing et al. [10]
demonstrated that every year of life increases the probability
of post-operative adverse events after TKA by 2%. However,
demographic projections demonstrated that individuals older
than 85 years represent the most rapidly growing cohort of
patients in the USA that will account for 2.3% of the popula-
tion in 2030 and 4.3% in 2050 [11]. Therefore, the demand for
TKA from patients who exceeded their estimated life expec-
tancy is projected to grow accordingly confronting total knee
surgeons to new paradigm and challenge [12, 13].
Previous studies reported significant improvement in
QALY after total hip and knee arthroplasty in global cohorts
of patients [14–17]. However, to our knowledge, no study was
dedicated to evaluate the improvement in quality of life that
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could be expected after TKA in patients who exceeded their
estimated life expectancy at the time of surgery in order to
balance the risk-benefit ratio of this elective procedure in these
specific patients [18, 19]. Therefore, this retrospective study
on prospectively collected data aimed to evaluate the function-
al outcome, rates of complication and mortality, and QALY in
a consecutive cohort of patients who exceeded their estimated
life expectancy at the time of TKA.
Patients and methods
Patients
From 2015 to 2018, patients who underwent TKA for end-
stage primary knee OA were prospectively included in our
institutional joint registry. Patient’s informed consent and
Institutional Review Board approval were obtained before ini-
tiating this study (CER-VD# 2020-00832). Through review of
the clinical and operative reports, a continuous series of 97
TKA performed in 86 patients who exceeded their estimated
life expectancy at the time of surgery (i.e., ≥ 83 years in 2015
in Switzerland [20]) was then identified and retrospectively
analyzed at latest follow-up.
There were 62 women and 24 men. The mean body mass
index was 27 ± 4 kg/m2. The mean age at the time of surgery
was 86 ± three years (Fig. 1). Particularly, 11 patients (13%,
two men, nine women, 11 TKA) were older than 90 with the
oldest patient being a 98-year-old woman. According to the
American Society of Anesthesiologists (ASA) physical status
classification, 46 patients (53%) were ASA II and 40 patients
(47%) were ASA III. No patient was ASA IV or presented
with terminal illness at the time of surgery. The main patients’
comorbidities are reported in Table 1. Before TKA, all of the
patients were active, independent in their daily living activi-
ties, and cognitively preserved. In addition, none of them was
living in a skilled nursing facility pre-operatively. The mean
follow-up of the entire series was of three ± one years at the
latest evaluation or until death.
Peri-operative care and surgical procedure
Before surgery, all the patients were evaluated for chronic anae-
mia according to recommendations of our institutional blood
management program and optimizedwhen haemoglobinwas <
10 mg/L with the objective to obtain a pre-surgical
haemoglobin level of 13 mg/L [21]. Twenty-one patients
(24%) received intravenous iron supplementation and/or blood
transfusion before TKA. In patients suffering from diabetes,
blood glucose was also evaluated and then optimized when
required with short-acting subcutaneous insulin regimen from
48 hours before surgery to 48 hours post-operatively.
All the TKA were performed by or under the direct super-
vision of a senior fellowship-trained arthroplasty surgeon
through a conventional medial parapatellar approach without
tourniquet in supine position under spinal (67 TKA, 69%) or
general (30 TKA, 31%) anaesthesia. A conventional antibiotic
prophylaxis with cefuroxime (or clindamycin in case of aller-
gy) was intravenously administered before skin incision.
Intravenous tranexamic acid was systematically administered
intra-operatively. A conventional primary cemented postero-
stabilized total knee system with patellar resurfacing was used
and implanted with the use a conventional technique with
mechanical alignment of the knee. No TKA required addition-
al procedure such as hardware removal, combined osteotomy,
or bone reconstruction. Before knee closure, an antalgic peri-
articular infiltration with ropivacaine and a haemostatic intra-
articular injection of tranexamic acid were systematically per-
formed. Then, the surgical incision was closed without drain-
age and the wound was covered with a sterile hydrocolloid
dressing for seven days.
A conventional rapid rehabilitation protocol that includes
multimodal pain management, immediate full weight–bearing
ambulation with a walker or crutches, and complete range of
motion knee mobilization was systematically prescribed and
adapted to the patient as tolerated. Postoperative blood
Table 1 Main comorbidities of the patients before TKA
Medical comorbidities Number of patients (%)
Hypertension 56 (65)
Diabetes 17 (20)
Chronic anemia 16 (19)
Supraventricular arrhythmia 15 (17)
Chronic renal failure 15 (17)
Ischemic heart disease 13 (15)
Thromboembolic disease 10 (12)
Obesity 10 (12)
Chronic obstructive pulmonary disease 7 (8)
Cerebrovascular accident 4 (5)
Obstructive sleep apnea 3 (4)
Fig. 1 Patients’ age at surgery: patient number by age and mean of age at
surgery
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management was performed according to the guidelines of the
British Committee for standards in blood transfusion for acute
anaemia [22]. The transfusion threshold of haemoglobin was
10 mg/L in patients with cardiovascular diseases and 7 mg/L in
the other patients, and adapted according to symptoms of acute
anemia. Oral laxative medication was systematically adminis-
tered to prevent constipation related to bed resting and opioids.
A bladder catheter was used only as needed in patients with acute
post-operative urinary retention. All the patients received a
thrombosis prevention with lower limb compression stocking
and thromboprophylaxis with subcutaneous enoxaparin during
30 days. Patients were discharged out of the hospital when pain
was adequately controlled with oral medication and independent
ambulation achieved with two crutches and knee flexion ≥ 90°.
Skin staples were removed at the 15th post-operative day at our
outpatient clinic facility.
Evaluation
Operative and anesthesiology reports were reviewed for as-
sessment of the operative time from the skin incision to wound
dressing, intra-operative bleeding by measuring fluid accumu-
lation in the suction device after subtracting irrigation and
weighing gauze swabs, occurrence of intra-operative compli-
cation, and the need for post-operative intermediate (IMCU)
or intensive (ICU) care unit. After TKA, the duration of in-
hospital stays and discharge disposition (i.e., patient’s home,
acute rehabilitation facility, or in-hospital death) were report-
ed. Medical reports were reviewed for post-operative in-hos-
pital medical and surgical complications.
Patients returned for post-operative follow-up visits at three
months, six months, one year, and annually thereafter.
Patients underwent a physical examination by the operating
surgeon. Plain long leg, Merchant view, antero-posterior, and
lateral radiographs of the affected knee were obtained. The
functional outcome was evaluated with the Knee Society
Score (KSS; part 1—Knee score, part 2—Function score
and Total KSS). The minimal clinically important difference
(MCID) was 9 for the KSS knee score and 10 for the KSS
function score [23]. Patient’s pre-operative and post-operative
health status was measured with the EuroQol-5D (EQ-5D)
score [24]. Each question of the EQ-5D was scored and then
converted to EQ-5D utility score [14]. An EQ-5D utility score
of 1 equates to one QALY. One QALY equates to one year in
perfect health. QALY point values range from 1 (perfect
health) to 0 (death). The cumulative postoperative QALY at
an endpoint was calculated as:
“cumulative QALY ¼ years of life after TKA
 patient survivorship
 postoperative EQ−5D utility score”
The time point value of QALY at 1 year after TKA equals
the EQ-5D utility score at one year and allows to quantify the
pre- to one year post-operative improvement in QALY after
TKA [15, 25]. Finally, the post-operative complication, pa-
tient readmission, TKA re-operation or revision, and mortality
data were collected through retrospective chart review.
Statistical analysis
Data are presented as mean ± standard deviation. Comparison
of the pre- to post-operative continuous and quantitative var-
iables was performed using two-sample t tests with a level of
evidence set at p < 0.05. Patient survivorship analysis was
performed using Kaplan-Meier curves with 95% confidence
intervals (CI) using death at the endpoint. Statistical analyses




The mean intra-operative blood loss was 450 ± 200 mL. The
mean operative time was 118 ± 24 minutes. Intra-operative
medical complications related to anesthesiology occurred dur-
ing 11 TKA (11%), being arrhythmia in 6 TKA (6%) and
hypotension in 5 TKA (5%). Intra-operative surgical compli-
cations occurred during two TKA (2%), being two medial
condylar fractures that were treated with internal fixation
using lag screws without compromising the TKA procedure.
IMCU was required after 12 TKA (12%) due to pre-existing
medical comorbidities in patients with ASA III status. ICU
was required after one TKA (1%) to monitor a supraventricu-
lar arrhythmia.
At patient’s discharge, the disposition was a transfer to an
acute rehabilitation facility after 79 TKA (81%) and patient’s
home after 17 TKA (18%). The mean in-hospital stay duration
was nine ± four days and was significantly longer in patients
transferred to an acute rehabilitation facility compared to those
discharged at home (9 ± 4 vs. 6 ± 3 days, respectively; p < 0.01).
Complications and mortality
Post-operative medical complications related to anesthesiolo-
gy included urinary retention after 12 TKA (12%) conducted
under spinal anaesthesia and acute confusion after six TKA
(6%) conducted under general anaesthesia. Minor medical
complications related to the surgical procedure were post-
operative anaemia requiring blood transfusion after 13 TKA
(13%). A major life-threatening medical complication was
reported after ten TKA (10%) (Table 2).
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After discharge, surgical complications were reported
after three TKA (3%) which required patient readmission
and TKA re-operation. There were one wound dehiscence
that was managed with debridement, one severe
haematoma that was managed with drainage, and one
periprosthetic distal femoral fracture without implant loos-
ening related to a fall that was managed with open reduc-
tion and internal fixation. Importantly, no TKA was re-
vised at latest follow-up.
Regarding mortality, one case of in-hospital death (1%)
was reported in a 94-year-old male patient with ASA III
status who deceased of congestive heart failure and acute
renal failure nine days after TKA. No other patient died
within the first post-operative month. Therefore, the 30-
day mortality was 1%. One after TKA, three patients died
from causes that were not related to TKA. Therefore, the
one year mortality was 3%. The patient survivorship at
one year and five years after TKA was 96% (95% CI: 84–
99%) and 84% (95% CI: 67–93%), respectively (Fig. 2).
Functional outcome and QALY
At a mean follow-up of three ± one years, the pre- to post-
operative total, knee, and function KSS scores improved sig-
nificantly (p < 0.01) (Table 3). Importantly, no patient experi-
enced worst function or pain at latest follow-up after TKA.
The pre- to one year post-operative QALY improved sig-
nificantly from 0.58 ± 0.25 to 0.90 ± 0.11 (p < 0.01).
Importantly, this improvement in QALY was significant for
all the patients. No patient obtained worst EQ-5D utility score
one year after TKA. The cumulative QALY five years after
TKA was four years. Assuming that these elderly patients
with end-stage knee OA did not undergo TKAwith no change
in their pre-operative value of EQ-5D utility score over time,
their cumulative QALY at five years would have been only
two years.
Discussion
End-stage knee OA is a leading cause of disabling pain, func-
tional impairment, and decline in quality of life [1]. Along
with the worldwide population aging and increase in life ex-
pectancy, the number of elderly patients undergoing TKA and
their functional demand in daily living activities are growing
[11, 12]. Due to pre-existing comorbidities and sometimes-
low physiological reserves, the risks of post-operative adverse
event and 30-day mortality were reported to be significantly
higher after total hip and knee arthroplasty when performed in
elderly patients [5–10]. However, the benefit of TKA in terms
of improvement in quality of life in these patients is sparsely
evaluated in literature, mainly through global cohorts of pa-
tients [15, 16, 26]. Indeed, no previous study to our knowl-
edge was specifically dedicated to evaluate the improvement
in quality of life after TKA in patients who exceeded their
expected life expectancy at the time of surgery. This lack of
knowledge confronts the surgeon with a difficult shared
decision-making process when balancing the risk-benefit ratio
of TKA in these particular patients. Therefore, this study was
dedicated to evaluate the functional outcome, rates of compli-
cation and mortality, and QALY in a consecutive cohort of
knee OA patients who exceeded their estimated life expectan-
cy (i.e., ≥ 83 years in 2015 in Switzerland [20]) at the time of
TKA. The most important finding of this study was that the
cumulative QALY five years after TKA was four years.
Indeed, the pre- to post-operative improvement in functional
outcome was significant for all the patients, with no patient
experiencing worst function or pain at latest follow-up.
Importantly, assuming that these patients did not undergo
TKA, their cumulative QALY at five years would have been
only two years. Therefore, the benefit of TKA was to offer to
these patients the equivalent of two more years of life in per-
fect health with respect to their pre-operative knee OA
Table 2 Major medical complications that occurred after TKA
Major medical complication Number of TKA (%)
Acute renal failure 4 (4)
Pneumonia 1 (1)
Pulmonary embolism 1 (1)
Stroke 1 (1)
Myocardial infarction 1 (1)
Congestive heart failure 1 (1)
Upper gastrointestinal hemorrhage 1 (1)
Total 10 (10)
Fig. 2 Kaplan-Meier curve showing survivorship of elderly patients who
exceeded their estimated life expectancy at the time of TKA
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condition. In addition, the pre- to one year post-operative im-
provement in QALY was 0.32 that was higher than the im-
provement previously reported in other studies evaluating
TKA in global cohort of patients, ranging from 0.17 to 0.27
[15, 26]. Therefore, this difference highlights the fact that any
improvement in functional independence and pain relief pro-
vided by TKA in elderly patients has stronger positive effects
on their overall quality of life when compared to global co-
horts that included young patients. This conclusion is even
more important to be emphasized with the knowledge that
the remaining life expectancy of 83-year-old individuals in
the global population in Switzerland is projected to be seven
years according to the Federal Statistical Office [27].
Nevertheless, the main concern with elective TKA in el-
derly patients remains the increased risks of complication and
mortality related to pre-existing medical comorbidities and
limited physiological reserves. In our study, the readmission
rate was 3%. All the readmissions were related to non-specific
surgical complication that occurred after three TKA (3%)
leading to re-operation. Importantly, the surgical complica-
tions were not related to surgical site infection or implant
mechanical failure with no TKA being revised at latest fol-
low-up. In addition, no readmission for medical complication
was observed. These findings contrast with previous studies
reporting 30-day readmission rates up to 7% related to post-
operative medical complications or infection of the surgical
site [8, 9, 28, 29]. Pre-operatively, all the patients were eval-
uated for chronic anaemia and optimized when required with
intravenous iron supplementation and/or blood transfusion
with the objective to obtain a pre-surgical haemoglobin level
of 13 mg/L [21]. Although chronic anaemia is a common
comorbidity in elderly patients, Klausing et al. [10] demon-
strated that pre-operative haemoglobin level was a significant
and independent predictor of the overall risks of post-
operative complication, admission in ICMU/ICU, and mortal-
ity after TKA. In addition, Noticewala et al. [30] demonstrated
that every ten year augmentation in patient age increased twice
the probability of blood transfusion leading to a 30% rate of
blood transfusion in patients over 80 years. In our study, we
found that blood transfusion and admission in ICMU/ICU
were both required in 13% of the TKA. This lower blood
transfusion rate reported in our study could be explained by
a systematic pre-operative patient’s blood management pro-
gram that aimed to identify and correct pre-operative anaemia.
This could also explain our rates of 13% for admission to
IMCU or ICU and 1% for 30-day mortality that were lower
than those of previous similar series reporting rates up to 17%
and 3%, respectively [10, 14, 31–34]. In our study, the mean
in-hospital stay duration was nine days and was significantly
longer in patients transferred to an acute rehabilitation facility
compared to those discharged at home. This was in accor-
dance with previous studies reporting in-hospital stay duration
ranging from eight to 11 days after TKA in elderly patients
[35–37]. However, the difference of three days we observed
between these two groups of patients was mainly related to the
delay to obtain a bed in a geriatric rehabilitation facility.
Importantly, no patient required a transient or definitive
skilled nursing facility after TKA. This finding contrasts with
other studies that reported a transfer rate to skilled nursing
facility as high as 14% [8, 38, 39]. This could indicate that
the functional independence improved after TKA and that this
procedure did not affect the overall morbidity of the patients
evaluated in our cohort.
This study presented with some limitations. First, this study
was based on patient demographics and life expectancy pro-
jections in Switzerland. Therefore, a generalization of our
conclusions to the elderly patients from other countries might
not be applicable. Second, TKA were performed in elderly
patients who were active, functionally independent for daily
living activities, and cognitively preserved. Therefore, our re-
sults might not correspond to those of patients who do not
meet the criteria mentioned above. Third, this study was ret-
rospective in design and included all the patients with end-
stage knee OA that were selected and referred to our clinic
from corresponding primary care physicians or rheumatolo-
gists. Therefore, this study might have not included some
elderly patients that were not referred to our clinic due to a
poor health condition, despite severe knee OA.
Conclusion
TKA is an effective procedure for the treatment of end-stage
knee OA in patients who exceeded their estimated life expec-
tancy. TKA provided significant improvement in function and
quality of life without adversely affecting the overall morbid-
ity and mortality. Particularly, this study showed that the ben-
efit of TKA was to provide to these patients the equivalent of
Table 3 Pre- to post-operative
comparisons of the Knee Society
Score (KSS)
KSS Pre-operative (mean ± SD) Post-operative (mean ± SD) p
Part 1—Knee 48 ± 16 87 ± 11* <0.001
Part 2—Function 50 ± 16 91 ± 14** <0.001
Total KSS 99 ± 26 178 ± 22 <0.001
*Minimal clinically important difference = 9 [23]. **Minimal clinically important difference = 10 [23]
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two more years of life in perfect health with respect to their
pre-operative knee OA condition. Therefore, TKA should not
be contra-indicated in elderly patients based on their advanced
age alone, especially for those who are active, functionally
independent, and cognitively preserved. However, elderly pa-
tients with multiple pre-existing comorbidities should be care-
fully evaluated and optimized in the pre-operative period with
a TKA performed in an institution with appropriate support
regarding the potential need for IMCU or ICU.
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